These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 12215461)

  • 21. Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling.
    Oishi Y; Ozono R; Yano Y; Teranishi Y; Akishita M; Horiuchi M; Oshima T; Kambe M
    Hypertension; 2003 Mar; 41(3 Pt 2):814-8. PubMed ID: 12624001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
    Otsuka S; Sugano M; Makino N; Sawada S; Hata T; Niho Y
    Hypertension; 1998 Sep; 32(3):467-72. PubMed ID: 9740612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The renin-angiotensin system and experimental heart failure.
    Wollert KC; Drexler H
    Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
    Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
    Parlakpinar H; Ozer MK; Acet A
    Cytokine; 2011 Dec; 56(3):688-94. PubMed ID: 21975128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The angiotensin type II receptor tonically inhibits angiotensin- converting enzyme in AT2 null mutant mice.
    Hunley TE; Tamura M; Stoneking BJ; Nishimura H; Ichiki T; Inagami T; Kon V
    Kidney Int; 2000 Feb; 57(2):570-7. PubMed ID: 10652034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
    Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
    Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
    Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
    Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats.
    Taylor K; Patten RD; Smith JJ; Aronovitz MJ; Wight J; Salomon RN; Konstam MA
    J Cardiovasc Pharmacol; 1998 May; 31(5):654-60. PubMed ID: 9593063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy.
    Zhu YC; Zhu YZ; Gohlke P; Stauss HM; Unger T
    Am J Cardiol; 1997 Aug; 80(3A):110A-117A. PubMed ID: 9293963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
    Makino N; Sugano M; Otsuka S; Hata T
    Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathophysiological mechanisms of the renin-angiotensin system and its pharmacologic modification by ACE inhibitors or angiotensin II (type 1) receptor blockers in cardiovascular diseases].
    Huber K; Pachinger O; Pichler M; Klein W
    Z Kardiol; 1997 Apr; 86(4):239-50. PubMed ID: 9235795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney.
    Zhuo J; Ohishi M; Mendelsohn FA
    Hypertension; 1999 Jan; 33(1 Pt 2):347-53. PubMed ID: 9931128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release of preformed Ang II from myocytes mediates angiotensinogen and ET-1 gene overexpression in vivo via AT1 receptor.
    Amedeo Modesti P; Zecchi-Orlandini S; Vanni S; Polidori G; Bertolozzi I; Perna AM; Formigli L; Cecioni I; Coppo M; Boddi M; Serneri GG
    J Mol Cell Cardiol; 2002 Nov; 34(11):1491-500. PubMed ID: 12431448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension.
    Mahmud A; Feely J
    J Hum Hypertens; 2000 Sep; 14(9):541-6. PubMed ID: 10980584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression.
    Tsutsumi Y; Matsubara H; Ohkubo N; Mori Y; Nozawa Y; Murasawa S; Kijima K; Maruyama K; Masaki H; Moriguchi Y; Shibasaki Y; Kamihata H; Inada M; Iwasaka T
    Circ Res; 1998 Nov; 83(10):1035-46. PubMed ID: 9815151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transitory reduction in angiotensin AT2 receptor expression levels in postinfarct remodelling in rat myocardium.
    Lax CJ; Domenighetti AA; Pavia JM; Di Nicolantonio R; Curl CL; Morris MJ; Delbridge LM
    Clin Exp Pharmacol Physiol; 2004 Aug; 31(8):512-7. PubMed ID: 15298543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathophysiological function of angiotensin II AT1 and AT2 receptors and clinical application of AT1 antagonists].
    Matsubara H; Mori Y; Masaki H; Inada M
    Nihon Rinsho; 1998 Jul; 56(7):1912-8. PubMed ID: 9702075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.